CStone Pharmaceuticals — Board/Management Information 2018

Feb 13, 2018

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

==> picture [63 x 60] intentionally omitted <==

兗州煤業股份有限公司

YANZHOU COAL MINING COMPANY LIMITED

(A joint stock limited company incorporated in the People’s Republic of China with limited liability)

(Stock Code: 1171)

CHANGE OF

(1) PRINCIPAL PLACE OF BUSINESS IN HONG KONG; AND (2) PROCESS AGENT

The board of directors (the “ Board ”) of Yanzhou Coal Mining Company Limited (the “ Company ”) hereby announces that, the principal place of business of the Company in Hong Kong has been changed to 18/F, Tesbury Centre, 28 Queen’s Road East, Wanchai, Hong Kong, with immediate effect.

The Board further announces that, with effect from 13 February 2018, Ms. Tina Law (羅雅婷女士) has ceased to act as the authorized representative for accepting service of process and notices on behalf of the Company in Hong Kong (the “ Process Agent ”) under Part 16 of the Companies Ordinance (Chapter 622 of the Laws of Hong Kong) and Ms. Sharon Leung (梁穎嫻女士), the joint company secretary of the Company, has been appointed as the Process Agent.

By order of the Board Yanzhou Coal Mining Company Limited Li Xiyong Chairman of the Board

Zoucheng, Shandong Province, the PRC 13 February 2018

As at the date of this announcement, the directors of the Company are Mr. Li Xiyong, Mr. Li Wei, Mr. Wu Xiangqian, Mr. Wu Yuxiang, Mr. Guo Dechun, Mr. Zhao Qingchun and Mr. Guo Jun, and the independent non-executive directors of the Company are Mr. Kong Xiangguo, Mr. Cai Chang, Mr. Poon Chiu Kwok and Mr. Qi Anbang.